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We	 examined	 expressions	 of	 E-selectin	 and	 myeloperoxidase	 (MPO)	 in	 cerebral	 tissues	
after	 cerebral	 ischemia-reperfusion	 (CIR)	 in	 rats	 and	 evaluated	 neuroprotective	 effects	 of	
atorvastatin	 under	 these	 conditions.	 Immunohistochemical	 methods	 were	 used	 to	 detect	
E-selectin	 and	MPO	expressioning	 tissue.	Small	numbers	of	E-selectin-	 and	MPO-positive	
cells	were	observed	in	the	sham	group	within	4	to	24	h	time	intervals.	In	the	operation	group,	
numerous	 positive	 cells	 were	 found	 in	 the	 cortex	 and	 hippocampus	 after	 CIR.	 E-selectin	
expression	occurred	at	4	h,	peaked	at	12	h,	and	returned	to	nearly	normal	levels	at	24	h.	However,	
E-selectin	expression	in	the	intervention	(CIR	+	atorvastatin)	group	was	significantly	lower	
than	that	in	the	operation	group	at	each	time	(P	<	0.05).	Myeloperoxidase	had	nearly	similar	
timing	of	changes	in	E-selectin	expression,	and	MPO	expressions	at	different	time	points	in	
the	intervention	group	were	significantly	lower	than	those	in	the	operation	group	(P	<	0.05).	
Therefore,	expressions	of	E-selectin	and	MPO	change	dynamically	after	CIR.	Atorvastatin,	
an	agent	having	anti-inflammatory	properties,	demonstrates	an	obvious	protective	effect	with	
respect	to	acute	CIR-related	damage.	
KEYWORDS: cerebral ischemia-reperfusion (CIR), E-selectin, myeloperoxidase, 
atorvastatin, inflammation.
1Department	 of	 Neurology,	 Second	Xiangya	Hospital	 of	 the	 Central	 South	
University,	Changsha,	China.	
2	Departments	 of	 Geriatrics,	 Third	 Xiangya	 Hospital	 of	 the	 Central	 South	
University,	Changsha,	China.
Correspondence	should	be	addressed	to	X.	Tang	
(e-mail:	txq6633@126.com).
INTRODUCTION
Atorvastatin	is	a	lipid-lowering	drug	used	in	therapy	of	
cardio-cerebrovascular	diseases	where	hyperlipidemia	
is	a	significant	independent	risk	factor.	The	following	
questions	seem	to	be	logical:	 in	addition	to	the	lipid-
lowering	effect	in	the	above	diseases,	can	atorvastatin	
also	 play	 a	 role	 in	 some	 other	way,	 and	 can	 patients	
with	normal	blood	lipid	levels	use	statins?	
Stroke	is	one	of	the	three	greatest	threats	to	human	
health,	with	high	morbidity,	disability,	and	mortality.	
Cerebral	 ischemia-reperfusion	 is	 aggravated	 with	
inflammation,	 resulting	 in	 secondary	 injury	 to	
ischemic	 tissues	 [1,	2].	There	 is	a	 series	of	 reactions	
developing	after	CIR,	and	inflammation	is	one	of	 the	
main	 negative	 factors	 inducing	 secondary	 injury	 to	
ischemised	tissues.
E-select in	 plays	 an	 important 	 role	 in	 the	
inflammatory	 cascade	 after	 CIR.	 This	 agent	 is	 an	
inducible	 adhesion	molecule	 that	mediates	 adhesion	
between	 activated	 endothelial	 cells	 and	 neutrophils	
and	is	directly	involved	in	aggregation	and	infiltration	
of	 inflammatory	 cells.	Within	 the	 period	 following	
CIR	injury,	white	blood	cells	travel	through	the	blood	
vessel	wall,	interact	with	endothelial	cells,	and	release	
a	number	of	 inflammatory	 factors.	 In	brain	 ischemic	
tissues,	 the	 levels	 of	mRNA	 of	 adhesion	molecules	
are	significantly	increased,	large	amounts	of	adhesion	
molecules	are	synthesized,	and	the	level	of	E-selectin	
correlates	with	the	production	of	oxygen	free	radicals.	
Blocking	of	expression	of	E-selectin	and	suppression	
of	adhesion	processes	and	accumulation	of	neutrophils	
in	 the	 ischemic	 area	 can	 reduce	 death	 of	 neurons	
and	 limit	 the	 infarct	 volume.	This	may	 improve	 the	
prognosis	 in	 stroke	 patients.	 In	 models	 of	 cerebral	
ischemia,	 the	survival	 rate	of	animals	 increased	after	
anti-E-selectin	antibody	 treatment.	Myeloperoxidase,	
MPO,	 exists	 primarily	 in	 neutrophil	 azurophilic	
granules,	and	its	activity	is	a	reliable	index	accessing	
the	infiltration	of	neutrophils	in	the	tissues.
Statins	 function	 as	 both	 regulation	 and	 non-
regulation	agents	with	 respect	 to	 lipids.	 In	a	number	
of	 studies,	 it	 was	 shown	 that	 statins	 can	 provide	
protection	 against	 renal,	 pulmonary,	 and	 heart	
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ischemia-reperfusion	 injury	 [3-5].	However,	 there	 is	
no	information	about	the	effect	of	statins	in	the	case	of	
CIR	injury.	Our	experiments	were	aimed	at	modeling	
of	 CIR,	 observation	 of	 the	 levels	 of	 expression	
of	 E-selectin	 and	 MPO,	 and	 investigation	 of	 the	
mechanism	of	possible	 anti-inflammatory	 actions	of	
atorvastatin.	
METHODS
Animal Groups. Sprague-Dawley	rats	were	provided	
by	 the	 Laboratory	 animal	 center	 of	 the	 Xiangya	
Medical	 School	 of	 the	 Central	 South	 University	
(Changsha,	China).	A	 total	 of	 96	 rats	weighing	 from	
240	to	260	g	were	divided	randomly	into	three	groups,	
sham-operated,	 experimental	 (CIR),	 and	 intervention	
(CIR	+	atorvastatin)	groups.	 In	 the	 latter	group,	each	
rat	 received	 daily	 6.5	 mg/kg	 atorvastatin	 one	 week	
before	 the	 operation;	 atorvastatin	 was	 dissolved	 in	
0.9%	normal	saline	(NS)	and	administered	by	gavage;	
other	groups	were	given	a	gavage	of	NS	of	 the	 same	
volume.	 Each	 group	 was	 further	 divided	 into	 sub-
groups	surviving	4,	8,	12,	and	24	h	after	CIR.
Rat CIR Model.	 Focal	 CIR	was	modeled	 in	 rats	
according	to	the	Longa	suture	method	[6].	A	silicone-
coated	 nylon	 monofilament	 was	 inserted	 across	
bifurcation	of	 the	common	carotid	artery	 to	 the	 right	
internal	 carotid	 artery	 and	 then	 penetrated	 into	 the	
brain	 until	 a	 proximal	 occlusion	of	 the	 right	middle	
cerebral	artery	(MCA)	was	achieved.	After	2	hours	of	
occlusion,	the	filament	was	slowly	withdrawn	to	allow	
the	MCA	blood	supply	to	recover,	and	reperfusion	was	
allowed	 to	continue	 for	4,	8,	12	and	24	h.	Rats	were	
anesthetized	with	isoflurane	(4%	for	surgical	induction	
and	1.75%	for	 a	maintenance	dose)	 for	 surgery.	The	
body	temperature	was	maintained	at	37°C.	In	the	sham	
group,	 rats	 received	 only	 anesthesia	 and	 vascular	
separation.
Neurological Deficit Grading System. 	 After	
revival	 of	 the	 rats	 from	 anesthesia,	 we	 observed	
neurological	 symptoms	 before	 selecting	 materials.	
Neurological	 deficit	was	 estimated	 according	 to	 the	
Longa’s	 Score	 in	 the	 following	mode.	 Score	 0	 was	
given	 if	 the	 rat	demonstrated	no	symptoms	of	neural	
damage;	score	1	was	given	if	the	rat	couldn’t	be	fully	
extend	 the	 forelimbs;	 score	 2	 was	 given	 if	 the	 rat	
made	circling	movements	 to	 the	opposite	 side;	 score	 
3	 was	 given	 if	 the	 rat	 fell	 down	 to	 the	 opposite	
side,	 and	 score	 4	was	 used	 if	 the	 rat	 couldn’t	 walk	
spontaneously,	with	 the	 loss	 of	 consciousness.	 Rats	
receiving	scores	1	to	3	were	selected	as	observational	
objectives.
Tissue and Slice Processing.	Celiac	anesthesia	was	
achieved	 with	 10%	 novochlorhydrate	 (350	 mg/kg).	
After	 the	perfusion	procedure,	 the	entire	brain	 tissue	
was	 removed.	 We	 observed	 whether	 subarachnoid	
hemorrhage	occurred	 at	 the	 skull	 base,	 and	knocked	
out	the	ones	that	were	bleeding.	Then,	the	fixed	brain	
tissue	was	 sliced	 in	continuous	4-µm	 thick	coronary	
sections	sliced	between	 the	optic	chiasm	and	 leading	
edge	 of	 the	 pons,	 with	 conventional	 dehydration,	
hyalinization,	wax	soaking	and	embedding.
Triphenyl Tetrazolium Chloride (TTC) Staining. 
After	 anesthesia	 with	 10%	 novochlorhydrate,	 brain	
tissue	was	removed	from	the	skull	and	refrigerated	at	
–20°C	for	30	min.	After	that,	five	coronal	slices	were	
made	with	a	2	mm	interval	behind	the	frontal	pole	(at	
1,	 3,	 5,	 7,	 9,	 and	11	mm)	and	 incubated	 in	darkness	
for	30	min	with	2%	TTC-PBS	solution	at	a	constant	
temperature	 (37°C).	 Regions	 that	 were	 stained	 red	
were	 considered	 normal,	 while	 regions	 of	 cerebral	
infarction	 appeared	 white.	 After	 staining,	 sections	
were	fixed	for	24	h	with	10%	formaldehyde	solution,	
and	pictures	were	taken	with	a	digital	camera.
Immunohistochemical Staining. After	dewaxation	
and	 hydration,	 brain	 tissue	 paraffin	 sections	 were	
washed	with	 PBS	 buffer	 three	 times,	 each	 time	 for	 
5	min.	Then,	each	section	was	blocked	with	50	µl	of	
a	peroxidase-blocking	solution	(to	block	endogenous	
peroxidase	 activity)	 and	 incubated	 for	 10	 min	 at	
room	 temperature.	 Washed	 with	 PBS	 buffer	 three	
times,	 each	 section	 was	 incubated	 with	 50	 µl	 of	
nonimmunologic	 animal	 serum	 for	 10	min	 at	 room	
temperature	 prior	 to	 overnight	 incubation	 at	 4°C	
with	50	µl	monoclonal	 rabbit	 anti-mouse	E-selectin	
antibody.	 Washed	 in	 PBS	 buffer	 (5	 min,	 3	 times)	
each	section	was	incubated	with	50	µl	biotin-labeled	
sheep	 anti-rat	 IgG	 and	 50	 µl	 Streptomyces-avidin-
peroxidase	solution	 for	10	min	at	 room	 temperature.	
Then	each	section	was	subjected	to	the	action	of	100	
µl	of	 freshly	prepared	AEC	solution	 for	10	min	and	
observed	 under	 a	 microscope.	 Brown-color	 cites	
were	 considered	 positive.	 Immunohistochemical	
results	were	 processed	by	 the	MIAS	medical	 image	
analysis	 system.	Average	 grey	 values	were	 selected	
to	stand	for	the	levels	of	expression	of	E-selectin	and	
MPO.	 Polyclonal	 E-selectin	 antibodies	 (1:100)	 and	
polyclonal	MPO	antibodies	 (1:100)	were	 purchased	
from	 Biosynthesis	 Biotechnology	 Co.	 (Beijing,	
China).	 Immunohistochemical	 staining	 protocols	
(SP	 method)	 and	 DAB	 coloration	 were	 used	 for	
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amplification	and	visualization.
Statistical Analysis.	 Numerical	 results	 are	 ex-
pressed	below	as	means	±	s.e.m.	Differences	between	
the	groups	were	estimated	by	ANOVA	or	the	LSD-test,	
and	those	with	P	<	0.05	were	considered	to	be	statisti-
cally	significant.
RESULTS
TTC Staining.	Brain	sections	in	the	sham	group	were	
uniformly	red	(Fig.	1A).	In	the	CIR	group,	blood	supply	
to	 the	 lateral	 regions	 was	 significantly	 reduced,	 as	
was	shown	by	the	presence	of	infarcted	white	regions	
(shown	in	Fig.	1B	with	black	arrow).	The	contralateral	
side	 remained	 red	 and,	 thus,	 well	 perfused.	 So,	 the	
CIR	model	was	found	to	be	successful.
E-Selectin Expression.	Positive	expression	looked	
as	was	tan-yellow	in	the	cell	boundaries	and	cytoplasm.	
In	 the	 sham	 group,	 immunohistochemical	 staining	
showed	 that	 little	 E-selectin	 expression	 appeared	
within	 the	 cortical	 areas	 supplied	 by	 the	 middle	
cerebral	 artery	 (4	h,	 8.44	±	1.27;	 8	h,	 12.59	±	0.80;	
12	h,	13.89	±	1.29,	and	24	h,	9.85	±	1.05;	Figs.	2A;	
4).	In	the	operation	(CIR)	group,	E-selectin	expression	
peaked	at	12	h	after	CIR.	There	was	intense	tan-yellow	
E-selectin-positive	immune	staining	in	the	ischemized	
cerebral	cortex	(4	h,	28.05	±	1.28;	8	h,	69.33	±	0.97;	
12	h,	84.19	±	1.06,	and	24	h,	60.43	±	1.33;	in	all	cases,	
P <	0.05;	Figs.	2B;	4).	Expression	of	E-selectin	in	the	
intervention	 (+	 atorvastatin)	 group	 peaked	 at	 12	 h	
after	CIR.	The	 level	of	expression	 in	each	 time	point	
in	 the	 intervention	group	was	statistically	 lower	 than	
that	in	the	operation	group,	but	higher	than	that	in	the	
sham	group	(4	h,	22.32	±	0.94;	8	h,	48.20	±	1.09;	12	h,	 
62.93	±	0.94,	and	24	h,	41.47	±	1.18;	P	<	0.05	 in	all	
cases;	Figs.	2C;	4).
MPO Expression.	Positive	cites	were	 tan	 in	 their	
color.	 In	 the	 sham	 group,	 immunohistochemical	
staining	showed	 that	 relatively	 low	MPO	expression	
appeared	 within	 the	 cortical	 areas	 supplied	 by	 the	
cerebral	artery	(4	h,	7.98	±	1.05;	8	h,	7.79	±	1.26;	12	h,	 
F i g. 1.	 Triphenyl	 tetrazolium	
chloride	staining	of	brain	sections	
in	 the	 sham	 (A)	 and	 operation	
(cerebral	 ischemia-reperfusion)	
group	(B).
Р и с. 1.	Забарвлення	зрізів	моз-
ку	 тріфенілтетразолієм	 у	 групі	
контролю	 (A)	 та	 групі	 тварин	
після	 церебральної	 ішемії–
реперфузії	(B).	
A
A
B
B C
F i g. 2.	Expression	of	E-selectin	in	the	sham	(A),	operation	(B),	and	intervention	(C)	groups;	12	h	after	sham	operation	(A)	and	cerebral	
ischemia-reperfusion	(B	and	C);	×400.
Р и с. 2.	Експресія	Е-селектину	в	контрольних	тварин	(А),	щурів	після	церебральної	ішемії–реперфузії	–	ЦІР	(В)	та	щурів	після	ЦІР	
і	введень	аторвастатину	(С).	
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8.22	 ±	 0.89,	 and	 24	 h,	 7.51	 ±	 1.17;	 Figs.	 3A;	 5).	
In	 the	 operation	 group,	 tan	 MPO	 immunostaining	
reached	the	maximum	in	the	ischemic	cerebral	cortex	 
12	hours	 after	CIR	 (4	 h,	 15.95	±	 2.00;	 8	 h,	 20.45	±	 
±	1.97;	12	h,	21.75	±	2.61,	and	24	h,	18.10	±	0.49;	P < 
<	0.05	in	comparisons	with	the	respective	sham	values;	
Figs.	3B;	5).	In	the	intervention	group,	MPO	expression	
also	peaked	at	12	h	after	CIR.	However, the	levels	of	
MPO	staining	at	all	time	points	were	significantly	lower	
than	 those	 in	 the	 operation	 group,	 but	 significantly	
higher	 than	 those	 in	 the	 sham	 group	 (4	 h,	 12.55	 ±	 
±	1.51;	8	h,	13.80	±	0.44;	12	h,	15.14	±	0.36,	and	24	h,	 
11.84	±	0.33;	P	<	0.05	in	all	cases;	Figs.	3C;	5).	
DISCUSSION
Recent researches indicated that excessive inflamma-
tion	 in	 cerebral	 tissues	 after	 CIR	 is	 one	 of	 the	 main	
causes	 of	 the	 reperfusion	 injury	 [7].	 Inflammation	 is	
A B C
F i g. 3.	Expression	of	myeloperoxidase	in	the	sham,	operation,	and	intervention	groups	(A-C,	respectively);	12	h.
Р и с. 3.	Експресія	мієлопероксидази	в	трьох	групах	тварин	(А–С	відповідно).
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F i g. 4.	Dynamics	of	E-selectin	expression	in	the	sham,	operation,	
and	 intervention	 groups	 (1-3,	 respectively).	 Abscissa)	 Time,	 h;	
ordinate)	optic	density	according	to	the	grey	scale.
Р и с. 4.	Динаміка	експресії	Е-селектину	в	трьох	групах	тварин	
(1–3	відповідно).	
F i g. 5.	 Dynamics	 of	 myeloperoxidase	 expression	 in	 the	 sham,	
operation,	and	intervention	groups	(1-3,	respectively).	Designations	
are	similar	to	those	in	Fig.	4.	
Р и с. 5.	Динаміка	експресії	мієлопероксидази	в	трьох	групах	
тварин	(1–3	відповідно).	
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3
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2
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characterized	by	infiltration	by	leukocytes,	activation	
of	vascular	endothelial	cells,	and	increase	in	the	level	
of	 adhesion	 molecules	 on	 the	 surface	 of	 leukocytes,	
which	 led	 to	 obstruction	 of	 microvessels	 by	 rolling	
and	adhering.	This	resulted	 in	 tissue	damage	because	
of	 crossing	 the	 endothelium	 tissue	 and	 releasing	 of	
such	factors	as	reactive	oxygen	species,	proteins,	and	
lipids	[8,	9].	In	some	studies,	it	was	demonstrated	that	
clearing	 from	peripheral	 leukocytes	and/or	 inhibiting	
of	 the	 activity	 of	 leukocytes	 with	 certain	 drugs	 can	
protect	cerebral	tissues	from	negative	consequences	of	
ischemia-reperfusion	[10,	11].	
Selectin	 is	 one	 of	 the	 members	 of	 the	 adhesion	
molecule	 family,	 and	 it	 began	 to	 undergo	 intense	
research	 since	 it	 was	 cloned	 in	 1989.	 The	 selectin	
family	includes	E-selectin,	L-selectin,	and	P-selectin.	
E-selectin	and	L-selectin	are,	 respectively,	expressed	
in	 endothelial	 cells	 and	 white	 blood	 cells,	 while	
P-selectin	 has	 been	 mainly	 found	 in	 platelets	 and	
endothelial	 cells.	Normal	 platelets	 have	 no	 of	 small	
amounts	 of	 P-selectin	 on	 their	 surface.	After	 CIR,	
P-selectin	 can	migrate	 to	 the	 surface	 of	 endothelial	
cells	 in	 a	 few	 minutes;	 it	 is	 involved	 in	 mediating	
initial	 adhesion	 of	 leukocytes	 and	 endothelial	 cells.	
Initial	P-selectin-mediated	adhesion	is	a	short-lasting	
and	 reversible	 process;	 further	 interactions	 between	
white	blood	cells	 and	endothelial	 cells	 are	mediated	
by	 E-selectin.	 This	 selectin	 plays	 an	 important	
role	 in	CIR-induced	 injury	 being	 involved	 in	 a	 late	
inflammatory	 response.	E-selectin	does	not	occur	on	
the	 surface	 of	 endothelial	 cells	 and	 is	 not	 activated	
until	endothelial	cells	are	stimulated	by	inflammation.	
This	is	in	accordance	with	our	results	that	low	levels	of	
E-selectin	expression	were	observed	in	the	sham	group,	
while	such	expression	was	dramatically	higher	 in	 the	
operation	group.	In	a	primate	stroke	model,	treatment	
with	antibodies	against	adhesion	molecular	 receptors	
reduced	a	“non-circulating	flow”	phenomenon.	In	the	
rat	model	with	 knockout	 of	 both	CD18 and CD26E 
genes,	adhesion	of	leukocytes	was	suppressed	by	95%.	
The	effects	with	respect	to	E-selectin	are	specific	and	
cannot	be	replaced	by	those	with	respect	to	any	other	
adhesion	 molecule	 [12].	 Glycogen	 with	 E-selectin	
antibody	can	crucially	reduce	adhesion	and	infiltration	
of	leukocytes,	leading	to	intensification	of	blood	flow	
in	 the	 ischemized	area	and	 limitation	of	 the	cerebral	
infarction	 area	 [13].	 Selectin	 is,	 at	 present,	 widely	
concerned	 as	 a	 new	 target	 for	 the	 drugs	 influencing	
adhesion	of	leukocytes	during	inflammation	[14].	
Immunohistochemistry	 showed	 that	 E-selectin	 is	
expressed	 in	 the	 ischemic	 lateral	 cortex,	 striatum,	
and	hippocampus.	Little	expression	was	observed	 in	
the	sham	group,	which	confirmed	what	was	 found	 in	
previous	studies	[15].	After	CIR,	E-selectin	expression	
demonstrated	clear	dynamics;	 it	 started	at	about	4	h,	
peaked	at	12	h,	and	remained	obvious	at	24	h	but	with	
noticeable	 reduction.	 This	 timing	 of	 expression	 is	
close	to	that	described	in	other	reports	[16,	17].	
Myeloperoxidase	 is	 a	 peroxidase	 enzyme	 that	
in	 humans	 is	 encoded	 by	 the	 MPO 	 gene.	 This	
peroxidase	is	most	abundantly	expressed	in	neutrophil	
granulocytes	 (a	 subtype	 of	 white	 blood	 cells)	 and	
stored	 in	 azurophilic	 granules,	 which	 is	 the	 most	
reliable	 assessment	 biomarker	 of	 infiltration	 of	
neutrophils	 in	 the	 tissue.	 In	 our	 experiments,	MPO	
was	expressed	in	the	ischemic	lateral	cortex,	striatum,	
and	 hippocampus.	 There	 were	 few	 MPO-positive	
cells	after	CIR	at	each	 time	point	 in	 the	sham	group,	
which	 agrees	with	 previous	 reports.	Compared	with	
the	above	(sham)	group,	there	were	much	more	MPO	
positive	 cells	 in	 the	 cortex	 and	 hippocampus	 after	
CIR.	 Expression	 of	MPO	 also	 changed	 dynamically	
(started	at	4	h,	peaked	at	12	h,	and	 remained	at	24	h	
with	significant	reduction).	Such	timing	of	expression	
is	 similar	 to	 changes	 of	 E-selectin	 expression.	 The	
degrees	 of	 changes	 correlated	 with	 the	 degrees	 of	
neurological	 deficit.	 Thus,	 it	 can	 be	 speculated	
that	 changes	 in	 E-selctin	 expression	 are	 positively	
associated	with	the	degree	of	inflammation.
Statins	 are	 defined	 as	 inhibitors	 of	 3-hydroxy-3-
methylglutaryl-coenzyme	A	 (HMG-CoA)	 reductase.	
These	 agents	 function	 better	 in	 reducing	 levels	 of	
low-density	 lipoproteins	 (LDLs)	 and	 other	 sorts	 of	
cholesterol-lowering	drugs;	meanwhile	 they	 increase	
the	 amount	 of	 high-density	 lipoproteins	 (HDLs).	 In	
addition,	 statins	 function	 “outside”	 of	 regulation	
of	 lipids,	 by	 improving	 the	 endothelial	 function,	
influencing	 the	 structure	 and	 stability	 of	 plaques,	
preventing	 thrombosis,	 and	 providing	 an	 anti-
inflammatory	action.	Mueck	et	al.	[18,	19]	found	that	
fluvastatin	can	decrease	the	level	of	ICAM-1,	VCAM-1,	 
and	E-selectin	in	a	dose-dependent	manner.
Our	 results	 showed	 that	 atorvastatin	 intervention	
statistically	 significantly	 decreases	 expression	 of	
E-selectin.	The	mechanism	of	cerebral	protection	by	
reducing	 E-selectin	 expression	 at	 present	 remains	
mostly	 unknown.	 However,	 according	 to	 some	
references,	it	is	probably	related	to	both	lipid-lowering	
and	non-lipid-lowering	functions	of	atorvastatin.	
Atorvastatin,	 when	 providing	 anti-inflammatory	
effects,	 lowers	 the	 levels	of	 triglycerydes,	cytokines	
(LDC-C	and	MCP-1)	and	increases	the	level	of	LDLs.	
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There	 is	 evidence	 that	 HDLs	 can	 inhibit	 E-selectin	
expression.	 Increased	 E-selectin	 expression	 in	 the	
umbilical	 vein	 in	 humans	 and	L1	 overexpressing	 in	
pig	aortic	endothelial	cells	may	be	inhibited	by	HDLs	
[20].	Thus,	it	can	be	speculated	that	atorvastatin	may	
raise	the	HDL	amount	to	reduce	E-selectin	expression	
and,	in	such	a	way,	contribute	to	cerebral	protection.	
NF-κB	 is	 a	 transcription	 factor	 widely	 expressed	
in	 eukaryotic	 cells,	 and	 it	 is	 proved	 to	 be	 activated	
under	 conditions	 of	 ischemic	 damage.	 Activated	 
NF-κB	 regulates	 a	 series	 of	 gene	 expressions.	
Atorvastatin	 and	 calcium	 can	 inhibit	 expression	 of	 
NF-κB	p65	mRNA	and	NF	protein	in	cerebral	tissues	
after	 ischemia-reperfusion,	 alleviating	 activation	
of	 NF-κB.	 The	 reduction	 of	 expression	 of	 pro-
inflammatory	 molecules,	 in	 particular	 of	 adhesion	
ones,	can	lead	to	alleviation	of	the	adhesion	processes	
and	 congregation	 and	 infiltration	 of	 leukocytes	 in	
the	 ischemia	 areas,	 contributing	 to	 the	 reduction	
of	CIR-related	 injury.	Schneider	 et	 al.	 [6]	 utilized	 a	
gene	knockout	technology	to	conclude	that,	after	p65 
knockout	 in	Wistar	 rats,	 the	 infarct	 volume,	 water	
content	 in	 cerebral	 tissues,	 and	 neurological	 deficit	
were	reduced	more	obviously	than	those	in	wild-type	
rats.	Thus,	it	was	concluded	that	activation	of	NF-κB	
can	aggravate	ischemic	injury	[6].	Similar	experiments	
were	 conducted	by	Liu	et	 al.	 [21].	Zhang	et	 al.	 [22]	
showed	 that	 NF-κB	 p65	 expression	 developed	 2	 h	
after	cerebral	ischemia,	peaked	at	12	h,	and	attenuated	
gradually	 at	 24	 h.	 The	 combination	 of	 TNF-β	 and	
its	 receptors	 can	 activate	 NF-κB	 signal	 pathway,	
leading	 to	 integration	 of	NF-κB	 in	 the	 core	 [23].	A	
general	explanation	 is	 that	activated	JNK/p38	kinase	
will	phosphorylate	c-JUN	and	bind	promoters	on	 the	
corresponding	sites	to	regulate	E-selectin	expression.	
It	 is	 probable	 that	 NF-κB	 expression	 is	 the	 key	
upstream	event	resulting	in	intensification	of	the	action	
of	 inflammatory	 factors	 and	 expression	 of	 adhesion	
molecules.	According	to	our	research,	it	is	likely	that	
atorvastatin	 impedes	combination	sites	of	E-selectin	
promoters	 in	 activated	 NF-κB,	 inhibits	 NF-κB	
signals,	 and	 reduces	activated	E-selectin	expression.	
Atorvastatin	 also	 inhibits	 the	 adhesion	 processes,	
limits	infiltration	of	leukocytes	and	vessel	endothelial	
cells,	 and	 in	 such	 a	 way	 contributes	 to	 cerebral	
protection	 by	 reducing	 pro-inflammatory	 damage	
after	CIR.	This	 statin	 is	a	promising	neuroprotective	
agent	 in	 the	 cases	 of	 such	 injury.	At	 the	 same	 time,	
the	specific	adjustment	path	 is	 in	 this	case	not	clear.	
We	 suspect	 that	may	 be	 there	 is	 a	 relationship	with	 
NF-κB;	so,	further	studies	of	the	atorvastatin	influence	on	 
NF-κB	 are	 expedient,	 to	 make	 clearer	 of	 how	
atorvastatin	 regulates	 inflammation	 to	 protect	 the	
brain	tissue	from	ischemic-reperfusion	injury.	
So, 	 administrat ion	 of	 atorvastatin	 afforded	
noticeable	 protection	 to	 nerve	 tissues	 against	 the	
inflammation	 response	 and	 lipemic-oxidative	 injury	
under	 conditions	 of	 CIR.	 Atrovastatin	 improved	
lipid	 parameters	 and	decreased	 the	 level	 of	 cerebral	
lipid	 peroxidation	 and	 inflammation.	 We	 conclude	
that	atorvastatin	 is	a	prospective	mean	 for	 treatment	
of	 ischemic	 cerebrovascular	 disease.	 Except	 lipid-
lowering	 effects,	 statins	 can	 bring	 the	 benefits	 for	
cerebrovascular	disease	patients	with	normal	levels	of	
blood	lipids.	At	the	same	time,	it	should	be	recognized	
that	only	one	dose	was	used	in	our	experiments,	and	a	
dose-effect	relationship	should	be	examined	in	future,	
to	 make	 application	 of	 atorvastatin	 in	 clinics	 more	
well-based.
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Р	е	з	ю	м	е
Ми	досліджували	експресію	Е-селектину	та	мієлоперокси-
дази	 (МПО)	у	тканинах	мозку	після	церебральної	 ішемії–
реперфузії	(ЦІР)	у	щурів	та	оцінювали	нейропротективний	
вплив	аторвастатину	в	цих	умовах.	Для	виявлення	експресії	
Е-селектину	та	МПО	були	застосовані	імуногістохімічні	ме-
тодики.	У	контрольній	групі	в	проміжку	4–24	год	спостері-
галися	невеликі	кількості	Е-селектин-	та	МПО-позитивних	
клітин.	У	групі,	підданій	ЦІР,	у	корі	та	гіпокампі	відмічалася	
велика	кількість	позитивних	клітин.	Експресія	Е-селектину	
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проявлялася	через	4	год,	досягала	максимуму	через	12	год	
та	поверталася	до	майже	нормальних	рівнів	через	24	год.	У	
той	же	час	експресія	Е-селектину	в	тварин,	котрим	уводили	
аторвастатин	після	ЦІР,	у	всіх	часових	проміжках	була	віро-
гідно	нижчою,	ніж	у	попередній	групі	(P < 0.05).	Експресія	
МПО	демонструвала	часовий	перебіг,	приблизно	подібний	
такому	в	 експресії	Е-селектину,	 і	 рівень	експресії	МПО	в	
усіх	часових	інтервалах	у	групі,	підданій	дії	аторвастатину,	
був	 істотно	нижчим,	ніж	у	групі	без	уведення	цього	аген-
та	 (P	<	0.05).	Отже,	 експресія	Е-селектину	та	МПО	після	
ЦІР	динамічно	змінюється;	аторвастатин	–	агент	з	антиза-
пальною	дією	–	продемонстрував	очевидний	протективний	
ефект	щодо	ушкоджень,	індукованих	гострою	ЦІР.	
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